跳至主要内容
临床试验/NCT04535843
NCT04535843招募中不适用

Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China

Huashan Hospital4 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2024年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
500
试验地点
4
主要终点
Myasthenia gravis foundation of America post intervention status

研究概览

简要总结

The present study is a prospective cohort study aiming to improve the clinical capacity in the diagnosis and natural history of Chinese patients with myasthenia gravis (MG). 300 MG patients are planned to recruit, document and prospectively follow up. Management of screening test and cohort manifestation are studied.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
0 Years 至 90 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • fluctuating muscle weakness and fatigability, along with one of the below:
  • more than 10% amplitude decrement in low frequency repetitive nerve stimulation,less than 10% amplitude increment in high frequency repetitive nerve stimulation;
  • anti-AChR or MuSK antibody positivity;
  • positive to the neostigmine test;
  • understanding and assigning the informed consent form, and having a good compliance with the follow up.

排除标准

  • excluding the possible diagnosis of Lambert-Eaton syndrome, congenital myasthenia syndrome,botulism injection, chronic progressive extraocular ophthalmoplegia, etc;
  • poor compliance to the follow up.

结局指标

主要结局

Myasthenia gravis foundation of America post intervention status

时间窗: 3 years

Myasthenia gravis foundation of America post intervention status (PIS) is assessed by the investigators during follow up. According to history inquiry and physical examination, participants are rated as clinical remission (no complain of myasthenia, no weakness at physical examination, and no therapies concerning MG for one year), pharmocological remission (no complain of myasthenia, no weakness at physical examination, but undertaking MG therapies at the last year), minimal manifestation (no complain of weakness, but showing weakness at physical examination), improvement (symptoms and signs), unchanged (symptoms and signs) , worsening(symptoms and signs), exacerbation(symptoms and signs), and death (medical record).

次要结局

  • Change From Baseline in Quantitative Myasthenia Gravis (QMG) Scores at the follow up(Baseline, 1 year, 2 year, and 3 year)
  • Change From Baseline in Activities of Daily Living (ADL) Scores at the follow up(Baseline, 1 year, 2 year, and 3 year)
  • Change From Baseline in Myasthenia Gravis-Quality of Life Questionnaire-15 item (MG-QOL15) Scores at the follow up(Baseline, 1 year, 2 year, and 3 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chongbo Zhao

Professor

Huashan Hospital

研究点 (4)

Loading locations...

相似试验